Tokyo, Japan

Shinzaburo Ohtake


Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shinzaburo Ohtake: Innovator in Pharmaceutical Treatments

Introduction

Shinzaburo Ohtake is a notable inventor based in Tokyo, Japan, known for his contributions to the field of pharmaceuticals. With a total of two patents, Ohtake has made significant strides in the therapeutic treatment of common health issues.

Latest Patents

Ohtake’s latest innovations include a method for the treatment of hypertension and a method for the treatment of diabetes. The hypertension treatment focuses on the administration of a vitamin E derivative, aimed at therapeutically managing high blood pressure effectively. Meanwhile, his diabetes treatment involves the oral or parenteral administration of Vitamin E nicotinate, which has demonstrated remarkable effects without causing injurious side effects.

Career Highlights

Shinzaburo Ohtake is currently associated with Eisai Company, Limited, where he continues to engage in research and development of effective therapeutic solutions. His work is characterized by a dedication to improving patient health outcomes through innovative treatments.

Collaborations

Throughout his career, Ohtake has collaborated with several esteemed colleagues, including Toshiji Igarashi and Hidetoshi Kawashima. These partnerships have been instrumental in advancing his research and enhancing the impact of his inventions within the pharmaceutical industry.

Conclusion

Shinzaburo Ohtake's contributions to the field of medicine underscore the importance of innovation in addressing public health challenges. His patents reflect a commitment to developing safe and effective treatments for hypertension and diabetes, showcasing the potential of vitamin E derivatives in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…